Dr. Molina Talks About Her Involvement in Clinical Trials

Video

Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About Her Involvement in New Clinical Trials

Ana M. Molina, M.D. Genitourinary Oncology Service from Memorial Sloan-Kettering Cancer Center in New York Talks About Her Involvement in New Clinical Trials

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD
Elias Jabbour, MD
Related Content
Updates and Advances in Early Stage Breast Cancer

Updates and Advances in Early Stage Breast Cancer

April 5th 2023
Article
Manali Kamdar, MD

Dr. Kamdar on the Results of the TRANSFORM Trial in Relapsed/Refractory LBCL

December 11th 2021
Article
Brandon Blue, MD

Dr. Blue on the Utility of Carfilzomib in Relapsed/Refractory Multiple Myeloma

October 1st 2021
Article
Randall Shares How Postoperative Radiotherapy Retains a Role in Soft Tissue Sarcoma

Randall Shares How Postoperative Radiotherapy Retains a Role in Soft Tissue Sarcoma

July 29th 2020
Article
Dr. Jacobson on the Benefit of Axi-Cel in Relapsed/Refractory Follicular Lymphoma

Dr. Jacobson on the Benefit of Axi-Cel in Relapsed/Refractory Follicular Lymphoma

June 11th 2020
Article
Dr. Katz on Determining Low-Risk Disease in Prostate Cancer

Dr. Katz on Determining Low-Risk Disease in Prostate Cancer

June 2nd 2020
Article